Wednesday, July 8, 2026

Patent intelligence · US

US 11395850

RSV vaccines and methods of production and use thereof

granted A61KA61K2039/5254A61K2039/575A61K39/12
Status granted
Linked drugs 1
Pipeline programs 6
Years to expiry 16
Applicant portfolio 8,292
Patent details — US 11395850
Jurisdiction
US
Status
granted
Grant date
Jul 26, 2022
Expiration
Jul 21, 2042
Claims
20
CPC classes
A61K, A61K2039/5254, A61K2039/575, A61K39/12
View on Google Patents ↗

Quick answer

US 11395850 (RSV vaccines and methods of production and use thereof) is held by The Board of Regents for Oklahoma State University. Status: granted. Granted Jul 26, 2022. Expires Jul 21, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
20
CPC classes
A61K, A61K2039/5254, A61K2039/575, A61K39/12, A61K39/39, A61P

More from The Board of Regents for Oklahoma State University

Related pharmaceutical patents in our USPTO index.

  1. US 12428463

    Chimeric antigen receptors targeting abnormal glycobiology

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Expires Sep 25, 2045

    granted
  2. US 12427148

    Cancer treatment targeted to tumor adaptive responses to protein synthesis stress

    The Regents of the University of California · Expires Sep 25, 2045

    granted
  3. US 12428416

    ERK inhibitors and uses thereof

    The Regents of the University of California · Expires Sep 25, 2045

    granted
  4. US 12427151

    Compositions and method of treating cancer

    The Regents of the University of California · Expires Sep 25, 2045

    granted
  5. US 12427197

    Methods of producing cobalt nanoparticles and hollow metal nanospheres

    The Regents of the University of California · Expires Sep 25, 2045

    granted
  6. US 12428489

    Human PD-L2 antibodies and methods of use therefor

    The Board of Regents of the University of Texas System · Expires Sep 25, 2045

    granted
  7. US 12427155

    Treatment for tau-related diseases

    The Regents of the University of California · Expires Sep 25, 2045

    granted
  8. US 12428455

    Dominant negative CEBPB and CEBPD proteins and methods of use for decreasing viability of neoplastic cells

    The Regents of the University of California · Expires Sep 25, 2045

    granted

Frequently asked questions

What is US patent 11395850?

US 11395850 (RSV vaccines and methods of production and use thereof) is held by The Board of Regents for Oklahoma State University. Status: granted. Granted Jul 26, 2022. Expires Jul 21, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 11395850?

The Board of Regents for Oklahoma State University is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 8,292 pharmaceutical patents for this assignee.

When does US 11395850 expire?

Our index shows an expiration date of Jul 21, 2042 (16 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.